Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer ConsortiumMiguel García-Pardo, Geoffrey Liu, Amy Chang et al.|Journal of Thoracic Oncology|2022Cited by 26
Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controlsXiaoyu Zhao, Juncheng Dai, Olga Y. Gorlova et al.|Cancer|2023Cited by 8
Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium DataSabine Schmid, Ping Yang, Mei Jiang et al.|Cancer Epidemiology Biomarkers & Prevention|2022Cited by 2
Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer ConsortiumMei Dong, Wei Xu, Abhinav Thakral et al.|Carcinogenesis|2025Cited by 0